ScinoPharm Taiwan, Ltd. (TPE:1789)
19.05
-0.15 (-0.78%)
May 9, 2025, 1:35 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
ScinoPharm Taiwan | 3.13B |
Log In |
Log In |
Log In |
Log In |
ScinoPharm Taiwan Growth | 5.26% |
Log In |
Log In |
Log In |
Log In |
Changshu ScinoParm | 275.04M |
Log In |
Log In |
Log In |
Log In |
Changshu ScinoParm Growth | 55.67% |
Log In |
Log In |
Log In |
Log In |
Other | 1.78M |
Log In |
Log In |
Log In |
Log In |
Other Growth | -95.09% |
Log In |
Log In |
Log In |
Log In |
Other | 1.78M |
Log In |
Log In |
Log In |
Log In |
Other Growth | -95.09% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Other | 36.07M |
Log In |
Log In |
Log In |
Log In |
Other Growth | 2.47% |
Log In |
Log In |
Log In |
Log In |
Asia | 1.42B |
Log In |
Log In |
Log In |
Log In |
Asia Growth | 20.62% |
Log In |
Log In |
Log In |
Log In |
Europe | 675.06M |
Log In |
Log In |
Log In |
Log In |
Europe Growth | -2.19% |
Log In |
Log In |
Log In |
Log In |
India | 529.29M |
Log In |
Log In |
Log In |
Log In |
India Growth | 0.77% |
Log In |
Log In |
Log In |
Log In |
United States | 403.66M |
Log In |
Log In |
Log In |
Log In |
United States Growth | -17.72% |
Log In |
Log In |
Log In |
Log In |
Taiwan | 346.88M |
Log In |
Log In |
Log In |
Log In |
Taiwan Growth | 27.76% |
Log In |
Log In |
Log In |
Log In |
Other | 36.07M |
Log In |
Log In |
Log In |
Log In |
Other Growth | 2.47% |
Log In |
Log In |
Log In |
Log In |